Galantamine for Cognitive Deficits in Schizophrenia

NCT00463879 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Galantamine

Sponsor

Yale University

Collaborators

[object Object]